PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34464977-3	2021	Similar interactions were observed with other HDACIs (MS-275) or IAP antagonists (birinapant).	birinapant	82-92	CD47 molecule	Homo sapiens	65-68	
30845975-0	2019	The IAP antagonist birinapant potentiates bortezomib anti-myeloma activity in vitro and in vivo.	birinapant	19-29	CD47 molecule	Homo sapiens	4-7	
30845975-2	2019	METHODS: Interactions between the clinically relevant IAP (inhibitor of apoptosis protein) antagonist birinapant (TL32711) and the proteasome inhibitor bortezomib were investigated in multiple myeloma (MM) cell lines and primary cells, as well as in vivo models.	birinapant	102-112	CD47 molecule	Homo sapiens	54-57